e-learning
resources
Munich 2014
Monday, 08.09.2014
Healthcare, prevention and adjunctive treatments in respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exacerbations in non-cystic fibrosis bronchiectasis
I. Sahnoun, H. Racil, S. Hafaied, S. Bacha, S. Cheikh Rouhou, N. Chawech, E. Mhiri, A. Chabbou (Tunis, Tunisia)
Source:
International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Session:
Healthcare, prevention and adjunctive treatments in respiratory infections
Session type:
Thematic Poster Session
Number:
2514
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Sahnoun, H. Racil, S. Hafaied, S. Bacha, S. Cheikh Rouhou, N. Chawech, E. Mhiri, A. Chabbou (Tunis, Tunisia). Exacerbations in non-cystic fibrosis bronchiectasis. Eur Respir J 2014; 44: Suppl. 58, 2514
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Predictors of lung function decline in stable non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
Clinical phenotypes in non-cystic fibrosis bronchiectasis (NCFBE)
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014
Predictors of exacerbations in patients with bronchiectasis
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Nicotinamide and bacterial killing in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014
Is etiology of non-cystic fibrosis bronchiectasis (NCFBE) a risk factor for severe exacerbation?
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Pneumonic vs. non-pneumonic exacerbations in bronchiectasis
Source: International Congress 2016 – Clinical update on bronchiectasis
Year: 2016
Exacerbations of bronchiectasis: Etiology and outcome
Source: International Congress 2016 – Orphan diseases II
Year: 2016
Positive microbiology findings in non-cystic fibrosis bronchiectasis and co-morbidities
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016
Aetiology of bronchiectasis: Evaluation of 319 adult patients with bronchiectasis
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016
Bronchiectasis
Source: Respipedia Article
Year: 2017
Co-existent rheumatoid arthritis and non-cystic fibrosis bronchiectasis: Evidence for more severe pulmonary disease using the bronchiectasis severity index (BSI)
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Frequency and pathogenicity of rhinovirus associated pulmonary exacerbations in patients with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
The weight of radiological severity in patients with non-CF bronchiectasis
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014
Adaptation of
prevotella
during acute infectious pulmonary exacerbation
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014
Role of stenotrophomonas maltophilia infection in CF pulmonary exacerbations
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Exacerbations and pneumonia in bronchiectasis: Clinical and microbiological characterization
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015
Pulmonary nocardiosis (PN) complicating chronic pulmonary diseases
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Respiratory infections in cystic fibrosis
Source: ERS Courses: Paediatric respiratory infections
Year: 2019
Prolonged antibiotics for non-cystic fibrosis purulent bronchiectasis in children and adults: A Cochrane review
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014
Clinicopathological features of the pulmonary aspergillosis with chronic interstitial pneumonia
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept